{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:21:49Z","timestamp":1789435309824,"version":"build-2803163510"},"reference-count":70,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2010,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1111\/j.1529-8019.2010.01308.x","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T16:22:31Z","timestamp":1269534151000},"page":"144-151","source":"Crossref","is-referenced-by-count":61,"title":["Psoriasis and cardiovascular disease"],"prefix":"10.1155","volume":"23","author":[{"given":"Gino A.","family":"Vena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Vestita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","article-title":"Psoriasis and occlusive vascular disease","volume":"99","author":"McDonald","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB2","first-page":"199","article-title":"High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients","volume":"40","author":"Ena","year":"1985","journal-title":"Acta Cardiol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000249365","article-title":"Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes","volume":"172","author":"Lindegard","year":"1986","journal-title":"Dermatologica"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB4","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1111\/1523-1747.ep12386079","article-title":"Epidemiology of psoriasis: clinical issues","volume":"102","author":"Krueger","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.135.12.1490","article-title":"Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis","volume":"135","author":"Poikolainen","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000121333","article-title":"Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002","volume":"217","author":"Kimball","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB9","first-page":"225","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur","volume":"19","author":"Mallbris","year":"2004","journal-title":"J Epidemiol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB10","article-title":"Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort","author":"Wakkee","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB11","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-3083.2009.03537.x","article-title":"Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample","author":"Schmitt","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB12","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-3083.2009.03481.x","article-title":"Subclinical atherosclerosis in patients with chronic psoriasis: a potential association","author":"El-Mongy","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","article-title":"Psoriasis: a possible risk factor for development of coronary artery calcification","volume":"156","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000182256","article-title":"Chronic plaque psoriasis is associated with increased arterial stiffness","volume":"218","author":"Gisondi","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0300-8932(09)70027-2","article-title":"Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement","volume":"62","author":"Soy","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archdermatol.2009.94","article-title":"Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality","volume":"145","author":"Prodanovich","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2008.08707.x","article-title":"Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis","volume":"159","author":"Kaye","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB19","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB20","first-page":"311","article-title":"Perfil ritmico em doentes com artrite psoriatica","volume":"9","author":"Carvalho","year":"1990","journal-title":"Rev Port Cardiol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arcmed.2006.08.004","article-title":"Heart rate and arrhythmia in patients with psoriasis vulgaris","volume":"38","author":"Markuszeski","year":"2007","journal-title":"Arch Med Res"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00403-008-0859-9","article-title":"Increased frequency of pulmonary hypertension in psoriasis patients","volume":"300","author":"Gunes","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archinte.1987.00370050184032","article-title":"Mitral valve prolapse in psoriatic arthritis","volume":"147","author":"Moya","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.1980.03310040045027","article-title":"Psoriatic arthritis and aortic regurgitation","volume":"244","author":"Muna","year":"1980","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1468-3083.2003.00748.x","article-title":"Echocardiographic findings in subjects with psoriatic arthropathy","volume":"17","author":"Saricaoglu","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/147323000603400608","article-title":"Echocardiographic and clinical abnormalities in patients with psoriasis","volume":"34","author":"Biyik","year":"2006","journal-title":"J Int Med Res"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2007.08.006","article-title":"Comorbidities in psoriasis","volume":"25","author":"Christophers","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaad.2006.09.017","article-title":"The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study","volume":"56","author":"Shapiro","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semarthrit.2005.12.002","article-title":"Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evidentcardiovascular disease or classic atherosclerotic risk factors","volume":"35","author":"Gonzalez-Juanatey","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000121605","article-title":"Psoriasis and dilated cardiomyopathy: coincidence or associated diseases?","volume":"111","author":"Eliakim-Raz","year":"2008","journal-title":"Cardiology"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2006.07.011","article-title":"Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients","volume":"190","author":"Wakkee","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB35","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB36","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archderm.141.12.1580","article-title":"Relationship between smoking and the clinical severity of psoriasis","volume":"141","author":"Fortes","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0738-081X(98)00040-6","article-title":"Cigarette smoking and psoriasis","volume":"16","author":"Naldi","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjmed.2007.06.020","article-title":"Smoking and the risk of psoriasis in women: Nurses' Health Study II","volume":"120","author":"Setty","year":"2007","journal-title":"Am J Med"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/eje.1.02057","article-title":"Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines","volume":"154","author":"Corbetta","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-0029-1222610","article-title":"Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors","volume":"35","author":"Gisondi","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB42","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard.2006.063867","article-title":"What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology","volume":"66","author":"Dixon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1529-8019.2008.01217.x","article-title":"Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis","volume":"22","author":"Channual","year":"2009","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jaad.2007.02.007","article-title":"Heart disease in psoriasis","volume":"57","author":"Kremers","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB47","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjcard.2008.10.004","article-title":"AJC editor's consensus: psoriasis and coronary artery disease","volume":"102","author":"Friedewald","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB48","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archderm.144.11.1518","article-title":"Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases","volume":"144","author":"Prodanovich","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the cytokine code in psoriasis","volume":"13","author":"Nickoloff","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaad.2007.07.016","article-title":"Interleukin-12, interleukin-23, and psoriasis: current prospects","volume":"57","author":"Torti","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.178.1.592","article-title":"An inflammatory pathway of IFN-gamma production in coronary atherosclerosis","volume":"178","author":"Ranjbaran","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB53","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE(-\/-) mice","author":"Xie","year":"2009","journal-title":"Cytokine"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB54","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.ATV.0000232502.88144.6f","article-title":"IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Chen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2008.08890.x","article-title":"Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model","volume":"160","author":"Stenderup","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1600-0625.2009.00926.x","article-title":"Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology","volume":"18","author":"Buback","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB57","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","article-title":"Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification","volume":"11","author":"Cho","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0021-9150(03)00298-3","article-title":"Plasma osteopontin levels are associated with the presence and extent of coronary artery disease","volume":"170","author":"Ohmori","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaad.2008.09.046","article-title":"Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis","volume":"60","author":"Chen","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00403-009-0939-5","article-title":"Osteopontin: a new emerging role in psoriasis","volume":"301","author":"Buommino","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB61","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.4049\/jimmunol.177.7.4267","article-title":"Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes","volume":"177","author":"Naldini","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB63","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","article-title":"Homocysteine: role and implications in atherosclerosis","volume":"8","author":"Guthikonda","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB64","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2006.07503.x","article-title":"Plasma homocysteine and folate levels in patients with chronic plaque psoriasis","volume":"155","author":"Malerba","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1468-3083.2008.03024.x","article-title":"Homocysteine, vitamin B12 and folic acid levels in psoriasis patients","volume":"23","author":"Cakmak","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09537100802082249","article-title":"Platelet function in cutaneous diseases","volume":"19","author":"Kasperska-Zajac","year":"2008","journal-title":"Platelets"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB67","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.0022-202X.2004.22318.x","article-title":"Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules","volume":"122","author":"Ludwig","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2332\/allergolint.O-08-537","article-title":"Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of thromboglobulin and platelet factor 4","volume":"57","author":"Tamagawa-Mineoka","year":"2008","journal-title":"Allergol Int"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB69","first-page":"207","article-title":"Is there an association between antiphospholipid antibodies and psoriasis?","volume":"22","author":"Cassano","year":"2008","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1111\/j.1529-8019.2010.01308.x-BIB70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2008.08874.x","article-title":"Psoriasis: an opportunity to identify cardiovascular risk","volume":"160","author":"Federman","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2010.01308.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2010.01308.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:57:53Z","timestamp":1671818273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2010.01308.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2010.01308.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}